학술논문
The Misleading "Pooled Effect Estimate" of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19).
Document Type
Letter to the Editor
Author
Source
Subject
*COVID-19
*TOCILIZUMAB
*
Language
ISSN
1058-4838